{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:15:42Z","timestamp":1772165742410,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T00:00:00Z","timestamp":1602633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T00:00:00Z","timestamp":1602633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Natural Science Foundation of China, the Young Investigator Award","award":["81300814"],"award-info":[{"award-number":["81300814"]}]},{"name":"Natural Science Foundation of China, the General program project","award":["81470069"],"award-info":[{"award-number":["81470069"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Increasing evidence indicates that the pathology and the modified Kadish system have some influence on the prognosis of esthesioneuroblastoma (ENB). However, an accurate system to combine pathology with a modified Kadish system has not been established.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This study aimed to set up and evaluate a model to predict overall survival (OS) accurately in ENB, including clinical characteristics, treatment and pathological variables. We screened the information of patients with ENB between January 1, 1976, and December 30, 2016 from the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) program as a training cohort. The validation cohort consisted of patients with ENB at Sun Yat-sen University Cancer Center and The First Affiliated Hospital of Sun Yat-sen University in the same period, and 87 patients were included. The Pearson\u2019s chi-squared test was used to assess significance of clinicopathological and demographic characteristics. We used the Cox proportional hazards model to examine univariate and multivariate analyses. The model coefficients were used to calculate the Hazard ratios (HR) with 95% confidence intervals (CI). Prognostic factors with a\n                      <jats:italic>p-<\/jats:italic>\n                      value &lt;\u20090.05 in multivariate analysis were included in the nomogram. The concordance index (c-index) and calibration curve were used to evaluate the predictive power of the nomogram.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The c-index of training cohort and validation cohort are 0.737 (95% CI, 0.709 to 0.765) and 0.791 (95% CI, 0.767 to 0.815) respectively. The calibration curves revealed a good agreement between the nomogram prediction and actual observation regarding the probability of 3-year and 5-year survival. We used a nomogram to calculate the 3-year and 5-year growth probability and stratified patients into three risk groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The nomogram provided the risk group information and identified mortality risk and can serve as a reference for designing a reasonable follow-up plan.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-020-07435-7","type":"journal-article","created":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T02:02:41Z","timestamp":1602640961000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A novel nomogram to predict the overall survival in esthesinoeroblastoma"],"prefix":"10.1186","volume":"20","author":[{"given":"Lijie","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tengjiao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenxiang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaofeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoqi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fenghong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianbo","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinyan","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,14]]},"reference":[{"issue":"2","key":"7435_CR1","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/BF00687075","volume":"75","author":"H Takahashi","year":"1987","unstructured":"Takahashi H, Ohara S, Yamada M, Ikuta F, Tanimura K, Honda Y. Esthesioneuroepithelioma: a tumor of true olfactory epithelium origin. Acta Neuropathol. 1987;75(2):147.","journal-title":"Acta Neuropathol"},{"issue":"2","key":"7435_CR2","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1097\/00020840-200304000-00009","volume":"11","author":"PJ Bradley","year":"2003","unstructured":"Bradley PJ, Jones NS, Robertson I. Diagnosis and management of esthesioneuroblastoma. Curr Opin Otolaryngol Head Neck Surg. 2003;11(2):112\u20138.","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"issue":"3","key":"7435_CR3","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1097\/00005537-200303000-00020","volume":"113","author":"VJ Lund","year":"2003","unstructured":"Lund VJ, Howard D, Wei W, Spittle M. Olfactory neuroblastoma: past, present, and future? Laryngoscope. 2003;113(3):502.","journal-title":"Laryngoscope"},{"issue":"11","key":"7435_CR4","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1002\/lary.23641","volume":"122","author":"CM Song","year":"2012","unstructured":"Song CM, Won TB, Lee CH, Kim DY, Rhee CS. Treatment modalities and outcomes of olfactory neuroblastoma. Laryngoscope. 2012;122(11):2389\u201395.","journal-title":"Laryngoscope"},{"key":"7435_CR5","first-page":"410","volume":"13","author":"L Berger","year":"1924","unstructured":"Berger L, Luc R, Richard D. L\u2019esthesioneuroepitheliome olfactif. Bull Assoc Fr Etude Cancer. 1924;13:410\u201321.","journal-title":"Bull Assoc Fr Etude Cancer."},{"issue":"11","key":"7435_CR6","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/S1470-2045(01)00558-7","volume":"2","author":"P Dulguerov","year":"2001","unstructured":"Dulguerov P, Allal AS, Calcaterra TC. Esthesioneuroblastoma: a meta-analysis and review. Lancet Oncol. 2001;2(11):683\u201390.","journal-title":"Lancet Oncol"},{"key":"7435_CR7","first-page":"240","volume-title":"Tumors of the upper respiratory tract and ear","author":"VJ Hyams","year":"1988","unstructured":"Hyams VJ. Olfactory neuroblastoma. In: Hyams VJ, Baksakis JG, Michaels L, editors. Tumors of the upper respiratory tract and ear. Washington DC: Armed Forces Institute of Pathology; 1988. p. 240\u20138."},{"issue":"1","key":"7435_CR8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s12105-014-0547-3","volume":"9","author":"D Bell","year":"2014","unstructured":"Bell D, Saade R, Roberts D, Ow TJ, Kupferman M, Demonte F, Hanna EY. Prognostic utility of Hyams histological grading and Kadish-Morita staging Systems for Esthesioneuroblastoma Outcomes. Head Neck Pathol. 2014;9(1):51\u20139.","journal-title":"Head Neck Pathol"},{"key":"7435_CR9","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1002\/1097-0142(197603)37:3<1571::AID-CNCR2820370347>3.0.CO;2-L","volume":"37","author":"S Kadish","year":"1976","unstructured":"Kadish S, Goodman M, Wang CC. Olfactory neuroblastoma. A clinical analysis of 17 cases. Cancer. 1976;37:1571\u20136.","journal-title":"Cancer"},{"issue":"5","key":"7435_CR10","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1227\/00006123-199305000-00002","volume":"32","author":"A Morita","year":"1993","unstructured":"Morita A, Ebersold MJ, Olsen KD, Foote RL, Lewis JE, Quast LMJN. Esthesioneuroblastoma: prognosis and management. Neurosurgery. 1993;32(5):706\u201314.","journal-title":"Neurosurgery"},{"issue":"3","key":"7435_CR11","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1001\/archotol.133.3.276","volume":"133","author":"D Jethanamest","year":"2007","unstructured":"Jethanamest D, Morris LG, Sikora AG, Kutler DI. Esthesioneuroblastoma: a population-based analysis of survival and prognostic factors. Arch Otolaryngol Head Neck Surg. 2007;133(3):276\u201380.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"2","key":"7435_CR12","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1177\/0194599815620173","volume":"154","author":"SB Nalavenkata","year":"2016","unstructured":"Nalavenkata SB, Sacks R, Adappa ND, Palmer JN, Purkey MT, Feldman MD, Schlosser RJ, Snyderman CH, Wang EW, Woodworth BA. Olfactory neuroblastoma: fate of the neck--a long-term multicenter retrospective study. Otolaryngol Head Neck Surgery. 2016;154(2):383.","journal-title":"Otolaryngol Head Neck Surgery"},{"issue":"6","key":"7435_CR13","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.ejca.2012.12.008","volume":"49","author":"GG Malouf","year":"2013","unstructured":"Malouf GG, Casiraghi O, Deutsch E, Guigay J, Temam S, Bourhis J. Low- and high-grade esthesioneuroblastomas display a distinct natural history and outcome. Eur J Cancer. 2013;49(6):1324\u201334.","journal-title":"Eur J Cancer"},{"issue":"2","key":"7435_CR14","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jocn.2012.05.029","volume":"20","author":"G Kaur","year":"2013","unstructured":"Kaur G, Kane AJ, Sughrue ME, Madden M, Oh MC, Sun MZ, Safaee M, El-Sayed I, Aghi M, Mcdermott MW. The prognostic implications of Hyam\u2019s subtype for patients with Kadish stage C esthesioneuroblastoma. J Clin Neurosci. 2013;20(2):281.","journal-title":"J Clin Neurosci."},{"issue":"4","key":"7435_CR15","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s12105-017-0781-6","volume":"11","author":"C Meyer","year":"2017","unstructured":"Meyer C, Hamersley ER, Manosalva RE, Torske K, Mcintyre N, Mitchell A. Olfactory neuroblastoma with divergent differentiation: an unusual histologic finding in a rare tumor. Head Neck Pathol. 2017;11(4):531.","journal-title":"Head Neck Pathol"},{"issue":"1","key":"7435_CR16","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s11912-014-0423-z","volume":"17","author":"RE Saade","year":"2015","unstructured":"Saade RE, Hanna EY, Bell D. Prognosis and biology in esthesioneuroblastoma: the emerging role of Hyams grading system. Curr Oncol Rep. 2015;17(1):423.","journal-title":"Curr Oncol Rep"},{"issue":"1","key":"7435_CR17","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s12885-017-3247-z","volume":"17","author":"L Xiong","year":"2017","unstructured":"Xiong L, Zeng XL, Guo CK, Liu AW, Huang L. Optimal treatment and prognostic factors for esthesioneuroblastoma: retrospective analysis of 187 Chinese patients. BMC Cancer. 2017;17(1):254.","journal-title":"BMC Cancer"},{"issue":"12","key":"7435_CR18","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1001\/jamaoto.2014.2541","volume":"140","author":"BA Tajudeen","year":"2014","unstructured":"Tajudeen BA, Arshi A, Suh JD, St John M, Wang MB. Importance of tumor grade in Esthesioneuroblastoma survival: a population-based analysis. JAMA Otolaryngol Head Neck Surg. 2014;140(12):1124.","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"8","key":"7435_CR19","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1200\/JCO.2007.12.9791","volume":"26","author":"A Iasonos","year":"2008","unstructured":"Iasonos A, Schrag D, Raj GV, Panageas KS. How to build and interpret a Nomogram for Cancer prognosis. J Clin Oncol. 2008;26(8):1364\u201370.","journal-title":"J Clin Oncol"},{"issue":"9","key":"7435_CR20","doi-asserted-by":"publisher","first-page":"774","DOI":"10.12998\/wjcc.v3.i9.774","volume":"3","author":"R Kumar","year":"2015","unstructured":"Kumar R. Esthesioneuroblastoma: multimodal management and review of literature. World J Clin Cases. 2015;3(9):774.","journal-title":"World J Clin Cases"},{"key":"7435_CR21","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.2147\/CMAR.S151945","volume":"10","author":"Z Yin","year":"2018","unstructured":"Yin Z, Wang Y, Wu Y, Zhang X, Wang F, Wang P, Tao Z, Yuan Z. Age distribution and age-related outcomes of olfactory neuroblastoma: a population-based analysis. Cancer Manag Res. 2018;10:1359\u201364.","journal-title":"Cancer Manag Res"},{"issue":"2","key":"7435_CR22","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s11060-008-9645-y","volume":"90","author":"AB Porter","year":"2008","unstructured":"Porter AB, Bernold DM, Giannini C, Foote RL, Link MJ, Olsen KD, Moynihan TJ, Buckner JC. Retrospective review of adjuvant chemotherapy for esthesioneuroblastoma. J Neuro-Oncol. 2008;90(2):201\u20134.","journal-title":"J Neuro-Oncol"},{"key":"7435_CR23","doi-asserted-by":"publisher","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","volume":"10","author":"RL Camp","year":"2004","unstructured":"Camp RL, Dolled-Filhart M, Rimm DL. X-tile: a new bio- informatics tool for biomarker assessment and outcome- based cut-point optimization. Clin Cancer Res. 2004;10:7252\u20139.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"7435_CR24","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/1471-2407-12-117","volume":"12","author":"G Bisogno","year":"2012","unstructured":"Bisogno G, Soloni P, Conte M, Podda M, Ferrari A, Garaventa A, Luksch R, Cecchetto G. Esthesioneuroblastoma in pediatric and adolescent age. A report from the TREP project in cooperation with the Italian Neuroblastoma and Soft Tissue Sarcoma Committees. BMC Cancer. 2012;12(1):117.","journal-title":"BMC Cancer"},{"issue":"2","key":"7435_CR25","doi-asserted-by":"publisher","first-page":"340","DOI":"10.3171\/2010.2.JNS091897","volume":"113","author":"AJ Kane","year":"2010","unstructured":"Kane AJ, Sughrue ME, Rutkowski MJ, Aranda D, Mills SA, Buencamino R, Fang S, Barani IJ, Parsa AT. Posttreatment prognosis of patients with esthesioneuroblastoma. J Neurosurg. 2010;113(2):340\u201351.","journal-title":"J Neurosurg"},{"issue":"05","key":"7435_CR26","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1055\/s-0032-1321512","volume":"73","author":"J Van Gompel","year":"2012","unstructured":"Van Gompel J, Giannini C, Olsen K, Moore E, Piccirilli M, Foote R, Buckner J, Link M. Long-term outcome of Esthesioneuroblastoma: Hyams grade predicts patient survival. J Neurol Surg B Skull Base. 2012;73(05):331\u20136.","journal-title":"J Neurol Surg B Skull Base"},{"issue":"9","key":"7435_CR27","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1002\/alr.22373","volume":"9","author":"K Goshtasbi","year":"2019","unstructured":"Goshtasbi K, Abiri A, Abouzari M, Sahyouni R, Wang BY, Tajudeen BA, Hsu FPK, Cadena G, Kuan EC. Hyams grading as a predictor of metastasis and overall survival in esthesioneuroblastoma: a meta-analysis. Int Forum Allergy Rhinol. 2019;9(9):1054\u201362.","journal-title":"Int Forum Allergy Rhinol"},{"issue":"1","key":"7435_CR28","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/jso.25293","volume":"119","author":"RR Joshi","year":"2019","unstructured":"Joshi RR, Husain Q, Roman BR, Cracchiolo J, Yu Y, Tsai J, Kang J, McBride S, Lee NY, Morris L, et al. Comparing Kadish, TNM, and the modified Dulguerov staging systems for esthesioneuroblastoma. J Surg Oncol. 2019;119(1):130\u201342.","journal-title":"J Surg Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-07435-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-020-07435-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-07435-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T19:40:23Z","timestamp":1634154023000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-020-07435-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,14]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["7435"],"URL":"https:\/\/doi.org\/10.1186\/s12885-020-07435-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-22163\/v4","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-22163\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-22163\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-22163\/v1","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,14]]},"assertion":[{"value":"17 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The retrospective study protocol was reviewed and approved by the Ethics Committee of The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China ([2020]111), with waiver of informed consent for Chinese cohort. Informed patient consent was not required for data released by the SEER database.The publication of research details under the Creative Commons Attribution License 4.0.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No conflict of interest exists in the submission of this manuscript. No conflict of interest exists in financial.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"993"}}